Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sihuan Pharmaceutical Holdings Group ( (HK:0460) ) has issued an update.
Sihuan Pharmaceutical Holdings Group announced a share repurchase of up to HK$500 million, with 1,500,000 shares already repurchased at an average price of HK$1.48 per share. This move aligns with the company’s strategic goals to strengthen its market position and shareholder value. The company has shown significant growth in its medical aesthetics and innovative pharmaceuticals segments, with a notable increase in revenue and the launch of several new products, which are expected to drive future growth.
The most recent analyst rating on (HK:0460) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Sihuan Pharmaceutical Holdings Group stock, see the HK:0460 Stock Forecast page.
More about Sihuan Pharmaceutical Holdings Group
Founded in 2001 and listed on the Main Board of the Stock Exchange in 2010, Sihuan Pharmaceutical is an international medical aesthetics and biopharmaceutical company led by innovation. It has a robust research and development platform, a comprehensive product pipeline, and a strong sales system, aiming to be a leader in China’s medical aesthetics and biopharmaceutical sectors.
Average Trading Volume: 89,428,691
Technical Sentiment Signal: Buy
Current Market Cap: HK$14.83B
For a thorough assessment of 0460 stock, go to TipRanks’ Stock Analysis page.